Suppressive effects of sivelestat on interleukin 8 and TNF-α production from LPS-stimulated granulocytes in whole blood culture

Journal of Anesthesia

Volumn 24, Issue 6, 2010, Pages 901-907

  Shibata, Shigehiro ^a   Takahashi, Gaku ^a   Shioya, Nobuki ^a   Inada, Katsuya ^a   Endo, Shigeatsu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Intracellular cytokine; Lipopolysaccharide; Sivelestat

Indexed keywords

INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; LIPOPOLYSACCHARIDE; SIVELESTAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MONOCYTE; NORMAL HUMAN; STAINING; UPREGULATION;

ACUTE LUNG INJURY; FLOW CYTOMETRY; GLYCINE; GRANULOCYTES; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MONOCYTES; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651512442     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-010-1030-2     Document Type: Article

References (28)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
2. H Nakae S Endo K Inada T Kasai M Yoshida 1994 Significance of alpha-tocopherol and interleukin 8 in septic adult respiratory distress syndrome Res Commun Chem Pathol Pharmacol 84 197 202 1:STN:280:DyaK2cznslOntA%3D%3D 8091005
3. S Endo K Inada Y Inoue Y Kuwata M Suzuki H Yamashita S Hoshi M Yoshida 1992 Two types of septic shock classified by the plasma levels of cytokines and endotoxin Circ Shock 38 264 274 1:STN:280:DyaK3s7osFWksA%3D%3D 1292890
4. S Endo K Inada Y Yamada T Kasai H Nakae M Kikuchi S Hoshi M Suzuki H Yamashita M Yoshida 1993 Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns Burns 19 124 127 1:STN:280:DyaK3s3ivVOrsQ%3D%3D 8471144 10.1016/0305-4179(93)90033-5
5. S Endo K Inada H Yamashita T Takakuwa H Nakae T Kasai M Kikuchi M Ogawa 1994 Platelet activating factor (PAF) acetyl hydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis Res Commun Chem Pathol Pharmacol 83 289 295 1:STN:280:DyaK2c3nvVagsA%3D%3D 8008978
6. S Endo K Inada M Ceska T Takakuwa Y Yamada H Nakae H Yamashita K Taki M Yoshida 1995 Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock J Inflamm 45 136 142 1:CAS:528:DyaK2MXosF2gtL0%3D 7583359
7. K Kawabata M Suzuki M Sugitani K Imaki M Toda T Miyamoto 1991 ONO-5046, a novel inhibitor of human neutrophil elastase Biochem Biophys Res Commun 177 814 820 1:CAS:528:DyaK3MXksVWqt7g%3D 2049103 10.1016/0006-291X(91)91862-7
8. N Suzuki Y Ishii S Kitamura 1994 Mechanism for the increased permeability in endothelial monolayers induced by elastase Mediators Inflamm 3 11 16 1:CAS:528:DyaK2cXjt1Sjtrw%3D 18472917 10.1155/S0962935194000025
9. K Kubo T Kobayashi T Hayano T Koizumi T Honda M Sekiguchi A Sakai 1994 Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep J Appl Physiol 77 1333 1340 1:CAS:528:DyaK2cXmslOrtbw%3D 7836137
10. S Endo N Sato Y Yaegashi Y Suzuki M Kojika Y Yamada Y Yoshida T Nakadate H Aoki Y Inoue 2006 Sivelestat sodium hydrade improves septic acute lung injury by reducing alveolar dysfunction Res Commun Mol Pathol Pharmacol. 119 53 65 1:CAS:528:DC%2BD2sXmt1Ohs7c%3D 17974096
11. Y Haga M Ogawa 1997 Neutrophil elastase inhibitor (ONO-5046•Na) decreases production of proinflammatory cytokines by lipopolysaccharide- stimulated human monocytes Res Commun Mol Pathol Pharmacol 98 243 248 1:CAS:528:DyaK1cXit1Gmurc%3D 9485518
12. T Misumi T Tanaka K Mikawa K Nishina O Morikawa H Obara 2006 Effects of sivelestat, a new elastase inhibitor, on IL-8 and MCP-1 production from stimulated human alveolar epithelial type II cells J Anesth 20 159 165 16897233 10.1007/s00540-006-0391-z
13. HK Yum J Arcaroli J Kupfner JM Penninger T Sasaki KY Yang JS Park E Abraham 2001 Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury J Immunol 167 6601 6608 1:CAS:528:DC%2BD3MXovVChsrg%3D 11714830
14. JA Nick SK Young PG Arndt JG Lieber BT Suratt KR Poch NJ Avdi KC Malcolm C Taube PM Henson GS Worthen 2002 Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase J Immunol 169 5260 5269 12391245
15. E Abraham 2003 Neutrophils and acute lung injury Crit Care Med 31 S195 S199 12682440 10.1097/01.CCM.0000057843.47705.E8
16. T Kawamura M Kadosaki N Nara J Wei S Endo K Inada 2005 Nicorandil attenuates NF-κB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery Shock 24 103 108 1:CAS:528:DC%2BD2MXpslGnsbc%3D 16044078 10.1097/01.shk.0000168874.83401.3f
17. DJ Kwak NH Augustine WG Borges JL Joyner WF Green HR Hill 2000 Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci Infect Immun 68 320 327 1:CAS:528:DC%2BD3cXhs1OgtQ%3D%3D 10603404 10.1128/IAI.68.1.320-327.2000
18. IT Young 1977 Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources J Histochem Cytochem 25 935 941 1:STN:280:DyaE2s3ltVOruw%3D%3D 894009
19. YP Agrawal E Hämäläinen EK Mahlamäki H Aho T Nousianinen R Lahtinen IM Penttilä 1992 Comparison of poly- and monoclonal antibodies for determination of B-cell clonal excess in an routine clinical laboratory Eur J Haematol 48 49 55 1:STN:280:DyaK387htFOjug%3D%3D 1730280 10.1111/j.1600-0609.1992.tb01793.x
20. L Madariaga D Suárez I Antón C Campelo P Lardelli R Cisterna 1992 Detection of the HIV p24 antigen on lymphocyte membranes using flow cytometry Enferm Infecc Microbiol Clin 10 592 596 1:STN:280: DyaK3s7osVShtw%3D%3D 1363372
21. M Nakashima M Kanamaru 1998 A phase I clinical study of a neutrophil elastase inhibitor; ONO-5046•Na in healthy volunteers (in Japanese with English abstract) Rinsho Iyaku (J Clin Ther Med) 14 195 218
22. K Kawabata T Hagio S Matsuoka 2002 The role of neutrophil elastase in acute lung injury Eur J Pharmacol 451 1 10 1:CAS:528:DC%2BD38XmvVCrs7g%3D 12223222 10.1016/S0014-2999(02)02182-9
23. I Nita C Hollander U Westin SM Janciauskiene 2005 Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release Respir Res 6 12 15683545 10.1186/1465-9921-6-12
24. JM Devaney CM Greene CC Taggart TP Carrol SJ O'Neill NG McElvaney 2003 Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4 FEBS Lett 544 129 132 1:CAS:528:DC%2BD3sXktFWlur0%3D 12782302 10.1016/S0014-5793(03) 00482-4
25. SJ Weiss 1989 Tissue destruction by neutrophils N Engl J Med 320 365 376 1:CAS:528:DyaL1MXhtleiu7Y%3D 2536474 10.1056/NEJM198902093200606
26. BG Zeiher S Matsuoka K Kawabata JE Repine 2002 Neutrophil elastase and acute lung injury: Prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics Crit Care Med 30 S281 S287 1:CAS:528: DC%2BD38Xktlykt7g%3D 12004249 10.1097/00003246-200205001-00018
27. TL Petty 1991 Protease mechanism in the pathogenesis of acute lung injury Ann N Y Acad Sci 624 267 277 1:STN:280:DyaK3M3ptVGgsQ%3D%3D 2064227 10.1111/j.1749-6632.1991.tb17025.x
28. M Miura S Endo Y Yamada 2001 Successful critical care of a patient with multiple trauma complicared by pulmonary edema and the fat embolism syndrome: usefulness of endobronchial administration of Ulinastatin Crit Care Shock 3 163 166